G&S Capital’s Lam Research LRCX Stock Holding History

G&S Capital’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-23,770	Closed	-$2.54M	–	125
2024 Q2	$2.54M	Sell	23,770 -670	-3%	-$64.3K	1.1%	35
2024 Q1	$2.37M	Sell	24,440 -3,640	-13%	-$320K	1.06%	38
2023 Q4	$2.2M	Buy	28,080 +350	+1%	+$23.9K	1.04%	38
2023 Q3	$1.74M	Sell	27,730 -6,540	-19%	-$430K	0.89%	52
2023 Q2	$2.2M	Sell	34,270 -740	-2%	-$41.7K	1.06%	35
2023 Q1	$1.86M	Buy	+35,010	New	+$1.72M	0.82%	41

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

G&S Capital's LRCX Position: Q3 2024 in Review

G&S Capital sold out of Lam Research (LRCX) in Q3 2024, closing a stake of 23,770 shares — an estimated $2.54M sold.

G&S Capital first reported a position in LRCX in Q1 2023 and held it in 6 quarters. The position peaked at $2.54M in Q2 2024. 1,465 funds tracked by Wall St. Rank hold LRCX as of Q3 2024.

G&S Capital reported no remaining Lam Research position as of Q3 2024 after selling out during the quarter.
G&S Capital sold 23,770 Lam Research shares in Q3 2024, an estimated $2.54M.
G&S Capital first reported a position in Lam Research in Q1 2023 and held it in 6 quarters.
G&S Capital's Lam Research position peaked at $2.54M in Q2 2024.
1,465 funds tracked by Wall St. Rank held Lam Research as of Q3 2024.

Based on G&S Capital's 13F filing for Q3 2024, filed 16 Oct 2024.